Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 615

Results For "RAT"

7943 News Found

Wipro GE Healthcare launches facility under govt’s PLI scheme
News | April 01, 2022

Wipro GE Healthcare launches facility under govt’s PLI scheme

It is one of the 15 medical device manufacturers approved under the government’s PLI scheme


Biocon Biologics’ partner receives positive EU CHMP opinion for biosimilar human insulin for IV infusion
Biotech | April 01, 2022

Biocon Biologics’ partner receives positive EU CHMP opinion for biosimilar human insulin for IV infusion

Celerity Pharmaceuticals uses Biocon Biologics’ insulin drug substance to develop the product


Premas Life Sciences to handle Beckman’s liquid handling solutions in India
Biotech | April 01, 2022

Premas Life Sciences to handle Beckman’s liquid handling solutions in India

Through this partnership, Premas will connect with genomics labs to provide automated NGS solutions


Dr Shravan Subramanyam, MD, Wipro GE Healthcare elected NATHEALTH President
News | April 01, 2022

Dr Shravan Subramanyam, MD, Wipro GE Healthcare elected NATHEALTH President

Highlights the need for rebuilding, restructuring, and re-imagining resilient healthcare systems in India


Oragnon enters global licencing agreement with Dare Biosciences
News | April 01, 2022

Oragnon enters global licencing agreement with Dare Biosciences

An estimated 21 million American women experience BV


Arzeda closes US$33 million Series B funding
Digitisation | April 01, 2022

Arzeda closes US$33 million Series B funding

Arzeda harnesses the power of computer-designed enzymes and applies the latest advances in digital biology


Sumitomo Chemical to build new API and intermediates plant in Japan
News | April 01, 2022

Sumitomo Chemical to build new API and intermediates plant in Japan

The plant is scheduled to come on stream in September 2024


Evonik restructures health care business
News | April 01, 2022

Evonik restructures health care business

The new structure further transitions the Health Care business line into a system solutions partner for the pharmaceutical and biotech industries


USFDA seeks more analysis on Merck’s BLA for Vaxneuvance
Biotech | April 01, 2022

USFDA seeks more analysis on Merck’s BLA for Vaxneuvance

No new studies have been requested


Dr. Reddy's to acquire cardiovascular brand Cidmus in India
News | April 01, 2022

Dr. Reddy's to acquire cardiovascular brand Cidmus in India

The Cidmus brand shall be affixed on the pharmaceutical composition comprising a combination of Valsartan and Sacubitril (currently under Novartis patent) which is indicated for heart failure patients with reduced ejection fraction